The next board meeting for Stoke Therapeutics Inc is on 18 Mar 2026 for the purpose of Stoke Therapeutics Inc Fourth Quarter Earnings Results for 2025See details
Stoke Therapeutics Inc has a share price target of US$ 42, revenue growth forecast of 416.4%, and profit growth estimate of 108.6% for FY25, based on top 12 analyst calls.